LIFECORE BIOMEDICAL, INC. Accrued Income Taxes, Current
LIFECORE BIOMEDICAL, INC. (LFCR) had Accrued Income Taxes, Current of $79.00 thousand as of 2016-02-28, per its 10-Q filed 2016-03-30.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2016-03-30
- 2016-02-28: Accrued Income Taxes, Current $79.00K.
- 2015-11-29: Accrued Income Taxes, Current $527.00K.
- 2015-08-30: Accrued Income Taxes, Current $104.00K.
- 2015-05-31: Accrued Income Taxes, Current $1.23M.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2016-02-28 | $79.00K 10-Q · filed 2016-03-30 |
| 2015-11-29 | $527.00K 10-Q · filed 2016-01-07 |
| 2015-08-30 | $104.00K 10-Q · filed 2015-10-01 |
| 2015-05-31 | $1.23M 10-Q · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |